Stay updated on LN-145 in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the LN-145 in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LN-145 in Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page’s footer revision/version identifier was updated to a newer technical build (v3.5.3 instead of v3.5.2), with no visible changes to the study details.
    Difference
    0.0%
    Check dated 2026-04-25T05:27:12.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    - Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T23:59:19.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Added Thyroid gland undifferentiated (anaplastic) carcinoma to the Conditions list. This expands the potential tumor types eligible for enrollment across the study.
    Difference
    0.0%
    Check dated 2026-04-03T17:31:02.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.0. No trial details, eligibility criteria, or outcomes were changed.
    Difference
    0.0%
    Check dated 2026-03-20T01:10:47.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T21:33:33.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Site-wide revision updated from v3.4.1 to v3.4.2; no changes to study data or patient-facing content are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T01:40:46.000Z thumbnail image

Stay in the know with updates to LN-145 in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LN-145 in Solid Tumors Clinical Trial page.